Latest AI and machine learning research in venous thrombosis for healthcare professionals.
Fondaparinux sodium is a synthetic low-molecular-weight heparin (LMWH). This medication is an anticoagulant or a blood thinner, prescribed for the treatment of pulmonary embolism and prevention and treatment of deep vein thrombosis. Its determination in the presence of related impurities was studied and validated by a novel ion-pair HPLC method. The separation of the drug and its degradation produ...
Determining the appropriate dosage of warfarin is an important yet challenging task. Several prediction models have been proposed to estimate a therapeutic dose for patients. The models are either clinical models which contain clinical and demographic variables or pharmacogenetic models which additionally contain the genetic variables. In this paper, a new methodology for warfarin dosing is propos...
BACKGROUND: Venous thromboembolisms (VTEs), which include deep vein thrombosis (DVT) and pulmonary embolism (PE), are associated with significant mort...
RGB-Thermal (RGBT) Video Object Detection (VOD) has gained significant traction due to its ability to overcome the limitations of conventional RGB-bas...
Background: Guiding risk-appropriate inpatient thromboprophylaxis requires venous thromboembolism (VTE) risk stratification; however, reliable risk de...
Background: In atrial fibrillation (AF), cerebral microbleed (CMB) burden guides anticoagulation decisions, yet AF is itself inconsistently associated...
Antiphospholipid syndrome (APS) lacks targeted therapies beyond anticoagulation, and its molecular heterogeneity remains poorly characterized. We empl...
Background: Current risk assessment tools for guiding direct oral anticoagulant (DOAC) therapy for patients with atrial fibrillation (AF) based on cli...
Objective: Electronic Health Record (EHR)-based trial emulation can support translation of randomized clinical trial (RCT) evidence into practice, yet...
Background and Purpose Embolic stroke of undetermined source (ESUS) emains a major diagnostic challenge in vascular neurology, as a substantial propor...
INTRODUCTION: Bleeding risk assessment plays a critical role in the anticoagulation management for atrial fibrillation (AF), to balance stroke prevent...
BACKGROUND: The occurrence of deep venous thrombosis (DVT) following total hip arthroplasty (THA) poses a substantial risk of morbidity and mortality,...
OBJECTIVE: Ultrasonography and D-dimer testing are established modalities for evaluating potential lower extremity deep venous thrombosis (DVT). The T...
Thrombotic Antiphospholipid Syndrome (TAPS) is an autoimmune disorder associated with a high risk of recurrent thromboembolic events. Despite advances...
Randomized controlled trials (RCTs) provide the highest level of clinical evidence but are often limited by cost, time, and ethical constraints. Emula...
Adherence to oral anticoagulants (OACs) for atrial fibrillation (AF) stroke prevention is traditionally defined as taking 80% of doses as prescribed, ...
Standardized assessment of clinical quality measures from electronic health records (EHRs) is challenging because information is fragmented across str...
Thrombophilia diagnosis and management rely on the nuanced interpretation of clinical history, risk factors, and laboratory data, yet significant vari...
Postoperative new-onset deep vein thrombosis (PNO-DVT) of the lower extremities represents a prevalent and serious clinical complication following pel...
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a major contributor to global morbidity and mortality, particularly during acute exacerbat...